Thrivent Financial for Lutherans boosted its stake in Cigna Group (NYSE:CI – Free Report) by 8.4% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 291,654 shares of the health services provider’s stock after acquiring an additional 22,721 shares during the period. Thrivent Financial for Lutherans’ holdings in Cigna Group were worth $84,069,000 as of its most recent filing with the SEC.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Solstein Capital LLC purchased a new position in shares of Cigna Group in the second quarter valued at $29,000. Harbor Capital Advisors Inc. lifted its holdings in Cigna Group by 119.5% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 90 shares of the health services provider’s stock worth $26,000 after purchasing an additional 49 shares in the last quarter. Chilton Capital Management LLC bought a new position in Cigna Group in the 2nd quarter worth about $30,000. Princeton Global Asset Management LLC boosted its stake in Cigna Group by 115.6% in the 2nd quarter. Princeton Global Asset Management LLC now owns 97 shares of the health services provider’s stock worth $32,000 after purchasing an additional 52 shares during the period. Finally, Quaker Wealth Management LLC grew its holdings in Cigna Group by 201.0% during the 2nd quarter. Quaker Wealth Management LLC now owns 106 shares of the health services provider’s stock valued at $35,000 after buying an additional 211 shares in the last quarter. 86.99% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
A number of equities analysts have recently commented on CI shares. JPMorgan Chase & Co. cut their price objective on shares of Cigna Group from $428.00 to $375.00 and set an “overweight” rating for the company in a research report on Tuesday, November 4th. UBS Group set a $294.00 target price on shares of Cigna Group in a research note on Wednesday, November 12th. Guggenheim restated a “buy” rating and set a $318.00 price target on shares of Cigna Group in a research report on Tuesday, December 2nd. Zacks Research raised shares of Cigna Group from a “strong sell” rating to a “hold” rating in a report on Monday, January 5th. Finally, TD Cowen set a $333.00 price objective on Cigna Group in a research report on Monday, December 15th. One investment analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and four have given a Hold rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $323.84.
Cigna Group Price Performance
CI stock opened at $273.69 on Monday. The firm has a market capitalization of $73.11 billion, a price-to-earnings ratio of 12.07, a PEG ratio of 0.97 and a beta of 0.27. The firm has a 50 day moving average price of $274.57 and a 200-day moving average price of $284.38. Cigna Group has a 52-week low of $239.51 and a 52-week high of $350.00. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.76 and a current ratio of 0.76.
Cigna Group (NYSE:CI – Get Free Report) last announced its quarterly earnings results on Thursday, October 30th. The health services provider reported $7.83 earnings per share for the quarter, beating the consensus estimate of $7.64 by $0.19. Cigna Group had a net margin of 2.29% and a return on equity of 18.80%. The company had revenue of $69.57 billion during the quarter, compared to the consensus estimate of $66.40 billion. During the same quarter last year, the firm earned $7.51 earnings per share. The firm’s quarterly revenue was up 9.5% compared to the same quarter last year. Equities research analysts forecast that Cigna Group will post 29.77 EPS for the current fiscal year.
About Cigna Group
Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.
In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.
Recommended Stories
- Five stocks we like better than Cigna Group
- Trump just signed it
- GOLD ALERT
- ALERT: Drop these 5 stocks before the market opens tomorrow!
- Trump’s Final Shocking Act Begins February 24
- What Expenses Can Be Deducted From Capital Gains Tax?
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI – Free Report).
Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.
